Lv3
240 积分 2022-11-12 加入
KDOQI Clinical Practice Guideline for Vascular Access: 2019 Update
1个月前
已完结
Temporary treatment cessation versus continuation of first-line tyrosine kinase inhibitor in patients with advanced clear cell renal cell carcinoma (STAR): an open-label, non-inferiority, randomised, controlled, phase 2/3 trial
3个月前
已完结
Renal Cell Cancer - Insights in Drug Resistance Mechanisms
3个月前
已完结
Prognostic Value of Thoracic Aorta Calcification Burden in Patients Treated With TAVR
8个月前
已完结
New Insights into the Role of FGF-23 and Klotho in Cardiovascular Disease in Chronic Kidney Disease Patients
11个月前
已完结
The role of klotho on vascular calcification and endothelial function in chronic kidney disease
11个月前
已完结
Targeting innate immunity-driven inflammation in CKD and cardiovascular disease
11个月前
已完结
Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: The lupus nephritis assessment with rituximab study
1年前
已完结
皖公网安备34019202002308
